---
title: "Unihealth Hospitals Ltd (UNIHEALTH) — Share Price, Financials & Analysis"
symbol: "UNIHEALTH"
company: "Unihealth Hospitals Ltd"
canonical: "https://tapetide.com/stocks/UNIHEALTH"
isin: "INE0PRF01011"
nse_symbol: "UNIHEALTH"
sector: "Healthcare"
industry: "Healthcare Services"
market_cap_cr: 1152.67
generated_at: "2026-09-13T18:26:51.943Z"
---

# Unihealth Hospitals Ltd (UNIHEALTH)

Canonical page: https://tapetide.com/stocks/UNIHEALTH

## Company

- **NSE Symbol:** UNIHEALTH
- **ISIN:** INE0PRF01011
- **Sector:** Healthcare
- **Industry:** Healthcare Services
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2023-09-21
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** unihealthonline.com

## About

Incorporated in 2010, Unihealth Consultancy Ltd is in the business of Medical Tour Operator and Health Consultancy Service & Trader in Medical Equipments[1]

## Latest Price

- **Price:** ₹712
- **Change:** -12.95 (-1.79%)
- **Open:** ₹718.8
- **Day High:** ₹718.8
- **Day Low:** ₹710
- **Previous Close:** ₹724.95
- **Volume:** 7500
- **As Of:** 2026-09-11T09:39:33+00:00

## Key Fundamentals

Observed at 2026-09-11T04:41:12.040619Z.

- **Market Cap:** ₹1152.67 Cr
- **Classification:** SME
- **P/E (reported):** 25.2
- **Book Value:** ₹87.5
- **Price to Book:** 8.29
- **Dividend Yield:** 0%
- **ROE:** 22.96%
- **ROCE:** 21.62%
- **Debt to Equity:** 0.24
- **Revenue (yearly):** ₹137 Cr
- **Net Income:** ₹45.4 Cr
- **EBITDA:** ₹58.8 Cr
- **52-Week High:** ₹820
- **52-Week Low:** ₹133.65
- **RSI (14):** 51.46

## Tapetide Score

- **Score:** 59 / 100
- **Score date:** 2026-09-04
- **Archetype:** Priced for Perfection
- **What it means:** The business scores well but the multiple leaves little room for error. The debate here is about the price, not the company; small disappointments tend to cost more at rich valuations.
- **Pillar profile:** Quality: Good · Valuation: Expensive · Momentum: Rising
- **Percentile:** 84.7 (of 4473 scored stocks)
- **Confidence:** 88%
- **Data coverage:** 76%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 60.72 | 9% |
| growth | 93.97 | 9% |
| momentum | 95.6 | 12% |
| ownership | 47.01 | 24% |
| quality | 61.48 | 22% |
| valuation | 40.49 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has delivered good profit growth of 38.6% CAGR over last 5 years

### Weaknesses

- Stock is trading at 8.12 times its book value
- Though the company is reporting repeated profits, it is not paying out dividend
- Tax rate seems low
- Company has high debtors of 341 days.

## Growth Rates

| Metric | 1Y | 3Y | 5Y |
| --- | --- | --- | --- |
| cash flow growth | 71.9% | 24.78% | -38.62% |
| ebitda margin growth | 10.64% | 12.8% | 29.23% |
| net income growth | 67.53% | 49% | 39% |
| revenue growth | 34.58% | 44% | 38% |
| roce | 0.84% | 26.36% | 20.18% |
| roe | 20.02% | 18.09% | -11.79% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Sales | 22 | 27 | 43 | 56 | 67 | 65 |
| Expenses | 15 | 16 | 28 | 34 | 35 | 43 |
| Operating Profit | 7 | 10 | 15 | 21 | 32 | 22 |
| OPM % | 32 | 39 | 35 | 38 | 48 | 34 |
| Other Income | 1 | 1 | 2 | 1 | 3 | 2 |
| Interest | 2 | 2 | 2 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 2 | 4 | 4 | 6 |
| Profit before tax | 5 | 8 | 13 | 18 | 30 | 17 |
| Tax % | 17 | 28 | 29 | -2 | 4 | -2 |
| Net Profit | 4 | 6 | 9 | 18 | 29 | 17 |
| EPS in Rs | — | — | — | — | 9.75 | 6.83 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 22 | 26 | 37 | 44 | 49 | 99 | 132 |
| Expenses | 20 | 20 | 25 | 30 | 31 | 62 | 78 |
| Operating Profit | 2 | 7 | 12 | 14 | 18 | 37 | 54 |
| OPM % | 10 | 25 | 31 | 31 | 36 | 37 | 41 |
| Other Income | 1 | 2 | 1 | 2 | 2 | 3 | 5 |
| Interest | 2 | 1 | 5 | 4 | 3 | 3 | 2 |
| Depreciation | 2 | 2 | 2 | 3 | 2 | 6 | 10 |
| Profit before tax | -1 | 5 | 5 | 9 | 14 | 30 | 46 |
| Tax % | 2 | 9 | 27 | 17 | 24 | 11 | 2 |
| Net Profit | -1 | 5 | 4 | 8 | 10 | 27 | 46 |
| EPS in Rs | — | — | — | — | — | — | 16.45 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 1 | 1 | 1 | 1 | 15 | 15 | 16 |
| Reserves | 4 | 9 | 13 | 26 | 70 | 86 | 122 |
| Borrowings | 41 | 39 | 38 | 39 | 15 | 22 | 33 |
| Other Liabilities | 12 | 9 | 12 | 12 | 10 | 62 | 84 |
| Total Liabilities | 58 | 58 | 65 | 78 | 110 | 185 | 254 |
| Fixed Assets | 35 | 35 | 36 | 37 | 36 | 68 | 84 |
| CWIP | 2 | 0 | 0 | 0 | 0 | 5 | 10 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 20 | 22 | 28 | 41 | 74 | 112 | 160 |
| Total Assets | 58 | 58 | 65 | 78 | 110 | 185 | 254 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1 | 4 | 9 | 1 | 5 | 3 | 6 |
| Cash from Investing Activity | -1 | 0 | -4 | -5 | 0 | -5 | -19 |
| Cash from Financing Activity | 1 | -3 | -5 | 3 | 22 | -3 | 16 |
| Net Cash Flow | 0 | 1 | 0 | 0 | 27 | -5 | 2 |
| Free Cash Flow | -1 | 4 | 8 | -1 | 2 | -13 | -26 |
| CFO/OP | 32 | 62 | 82 | 22 | 40 | 18 | 16 |

### Ratios

| Item | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 206 | 198 | 180 | 228 | 251 | 303 | 341 |
| Inventory Days | 50 | 86 | 78 | 98 | 88 | 74 | 100 |
| Days Payable | 382 | 91 | 79 | 137 | 104 | 104 | 138 |
| Cash Conversion Cycle | -125 | 192 | 180 | 188 | 235 | 273 | 304 |
| Working Capital Days | 24 | 137 | 87 | 141 | 203 | 239 | 321 |
| ROCE % | — | 14 | 20 | 22 | 20 | 25 | 24 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Promoters | 68.8% | 68.8% | 68.93% | 68.93% | 69.14% | 69.53% |
| FIIs | 5.61% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0.12% | 0.12% | 0% | 0% | 0.75% | 0.48% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 15.97% | 23.83% | 21.37% | 20.78% | 21.8% | 25.03% |
| Others | 9.49% | 7.25% | 9.69% | 10.29% | 8.31% | 4.96% |
| No. of Shareholders | 1826 | 979 | 984 | 985 | 1058 | 1162 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Neutral
- **Buy / Neutral / Sell:** 7 / 5 / 7

### Moving Averages — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 720.1 | Sell |
| EMA (10) | 719.68 | Sell |
| SMA (20) | 723.29 | Sell |
| EMA (20) | 722.05 | Sell |
| SMA (50) | 730.63 | Sell |
| EMA (50) | 697.21 | Buy |
| SMA (100) | 610.81 | Buy |
| EMA (100) | 623.08 | Buy |
| SMA (200) | 470.77 | Buy |
| EMA (200) | 507.36 | Buy |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 46.71 | Neutral |
| MACD (12,26,9) | -0.7 | Sell |
| Stochastic (14,3,3) | 62.69 | Neutral |
| ADX (14) | 14.86 | Neutral |
| Williams %R (14) | -29.94 | Neutral |
| ATR (14) | 28.8 | High Volatility |
| ROC (12) | 0.64 | Buy |
| Stoch RSI (14) | 11.55 | Buy |
| UO (7,14,28) | 70.48 | Sell |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 9 July 2026 - UniHealth Hospitals to attend virtual investor meet on July 14, 2026 at 12:00 p.m. | [Analysts/Institutional Investor Meet/Con. Call Updates 9 July 2026 - UniHealth Hospitals to attend virtual investor meet on July 14, 2026 at 12:00 p.m.](https://nsearchives.nseindia.com/corporate/UNIHEALTH_09072026125433_searchable.pdf) |
| 9 April 2026 - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026. | [Certificate under SEBI (Depositories and Participants) Regulations, 2018 9 April 2026 - Submitted Regulation 74(5) certificate for quarter ended 31 March 2026.](https://nsearchives.nseindia.com/corporate/UNIHEALTH_09042026125108_Reg_74_5__with_Covering_Letter.pdf) |
| 8 June 2026 - Transcript released for H2 FY26 results call; FY26 income rose 34.6%, profit 83%, beds doubled to 400. | [Analysts/Institutional Investor Meet/Con. Call Updates 8 June 2026 - Transcript released for H2 FY26 results call; FY26 income rose 34.6%, profit 83%, beds doubled to 400.](https://nsearchives.nseindia.com/corporate/UNIHEALTH_08062026180426_Earning_call_Transcript__1_.pdf) |
| 8 April 2026 - UniHealth schedules a virtual group analyst/institutional investor meeting on April 12, 2026 at 12:00 p.m. | [Analysts/Institutional Investor Meet/Con. Call Updates 8 April 2026 - UniHealth schedules a virtual group analyst/institutional investor meeting on April 12, 2026 at 12:00 p.m.](https://nsearchives.nseindia.com/corporate/UNIHEALTH_08042026123716_searchable.pdf) |
| 8 April 2026 - UniHealth says quarterly corporate governance report for quarter ended 31 March 2026 is not required on SME exchange. | [Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter 8 April 2026 - UniHealth says quarterly corporate governance report for quarter ended 31 March 2026 is not required on SME exchange.](https://nsearchives.nseindia.com/corporate/UNIHEALTH_08042026143950_searchable.pdf) |
| 7 Sep - Unihealth allotted 12.5 lakh shares at ₹520.31 each for Victoria Hospital acquisition via share swap. | [Allotment of Securities 7 Sep - Unihealth allotted 12.5 lakh shares at ₹520.31 each for Victoria Hospital acquisition via share swap.](https://nsearchives.nseindia.com/corporate/UNIHEALTH_07092026164043_Reg_30_-_ALLOTMENT-_Post_Allotment_Unihelath.pdf) |
| 7 March 2026 - Analyst/Institutional meeting on Feb 6, 2026 hosted by Arihant Capital, 3:00–4:10pm virtual; no UPSI shared. | [Analysts/Institutional Investor Meet/Con. Call Updates 7 March 2026 - Analyst/Institutional meeting on Feb 6, 2026 hosted by Arihant Capital, 3:00–4:10pm virtual; no UPSI shared.](https://nsearchives.nseindia.com/corporate/UNIHEALTH_07032026092245_Adobe_Scan_07_Mar_2026__1_.pdf) |
| 7 March 2026 - Analyst/institutional investors meeting held March 6, 2026 03:00–04:10; Arihant Capital Markets attended; no UPSI. | [Analysts/Institutional Investor Meet/Con. Call Updates 7 March 2026 - Analyst/institutional investors meeting held March 6, 2026 03:00–04:10; Arihant Capital Markets attended; no UPSI.](https://nsearchives.nseindia.com/corporate/UNIHEALTH_07032026114418_Adobe_Scan_07_Mar_2026__1___1_.pdf) |
| 6 July 2026 - AGM notice/annual report proposes 12.5 lakh preferential shares at ₹520.31 to acquire 49.81% Victoria Hospital Uganda. | [General Updates 6 July 2026 - AGM notice/annual report proposes 12.5 lakh preferential shares at ₹520.31 to acquire 49.81% Victoria Hospital Uganda.](https://nsearchives.nseindia.com/corporate/UNIHEALTH_06072026195545_AGM_Notice_merged.pdf) |
| 5 July 2026 - UniHealth approved preferential issue of up to 12.5 lakh shares for 49.81% Victoria Hospital acquisition. | [Issue of Securities 5 July 2026 - UniHealth approved preferential issue of up to 12.5 lakh shares for 49.81% Victoria Hospital acquisition.](https://nsearchives.nseindia.com/corporate/UNIHEALTH_05072026111107_UNIHEALTH_03072026191143_OutcomeofBoardMeeting.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Annual Report 2026 from nse](https://archives.nseindia.com/annual_reports/SME_AR_29591_UNIHEALTH_2025_2026_A_7915410_06072026185828.pdf) |
| from nse | [Annual Report 2025 from nse](https://archives.nseindia.com/annual_reports/SME_AR_28546_UNIHEALTH_2024_2025_A_4209907_05092025133451.pdf) |
| from nse | [Annual Report 2024 from nse](https://archives.nseindia.com/annual_reports/SME_AR_24962_UNIHEALTH_2023_2024_16082024124647.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://nsearchives.nseindia.com/corporate/UNIHEALTH_21112025160053_Earning_call-_Transcript_with_CV.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://nsearchives.nseindia.com/corporate/UNIHEALTH_15112024101532_cvandtrasncript_signed.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://nsearchives.nseindia.com/corporate/UNIHEALTH_21112023132648_UCLEarningcallTranscript.pdf) |
| May 2025 | [Concall - May 2025](https://nsearchives.nseindia.com/corporate/UNIHEALTH_30052025160654_Transcript_of_Earnings_call.pdf) |
| May 2024 | [Concall - May 2024](https://nsearchives.nseindia.com/corporate/UNIHEALTH_27052024140146_cvANDTranscript.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:26:51.943Z.